Thus, the specific clinical populations in which the assay might be useful include hospital in-patients with known HIV infection [15] and ambulatory out-patients with known HIV-infection and low CD4 cell counts such as those newly referred to antiretroviral treatment (ART) clinics [12]. The gene discussed is CD4; the disease is HIV infectious disease.